Literature DB >> 24154928

Remote monitoring of a high-risk patient with Brugada syndrome: association of different arrhythmic manifestations.

Sergio Richter1, Pedro Brugada.   

Abstract

We report on the remote arrhythmia monitoring of a 34-year-old man with highly symptomatic Brugada syndrome, who initially presented with syncope, paroxysmal atrial fibrillation, and spontaneous coved-type electrocardiogram. The patient received a dual-chamber implantable cardioverter-defibrillator (ICD) with Home Monitoring™ facilities and experienced recurrent ICD shocks for spontaneous ventricular fibrillation (VF) episodes during the first year after ICD implantation. Remote monitoring revealed an increased burden of premature ventricular complexes and atrial arrhythmias each time VF spontaneously occurred. Atrial and ventricular arrhythmias were effectively suppressed by low-dose quinidine without severe side effects.

Entities:  

Mesh:

Year:  2013        PMID: 24154928     DOI: 10.1007/s00399-013-0292-4

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  4 in total

1.  Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy.

Authors:  M Kakishita; T Kurita; K Matsuo; A Taguchi; K Suyama; W Shimizu; N Aihara; S Kamakura; F Yamamoto; J Kobayashi; Y Kosakai; T Ohe
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

Review 2.  Efficacy of quinidine in high-risk patients with Brugada syndrome.

Authors:  Bernard Belhassen; Aharon Glick; Sami Viskin
Journal:  Circulation       Date:  2004-09-20       Impact factor: 29.690

3.  Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome.

Authors:  Pierre Bordachar; Sylvain Reuter; Stephane Garrigue; Xu Caï; Mélèze Hocini; Pierre Jaïs; Michel Haïssaguerre; Jacques Clementy
Journal:  Eur Heart J       Date:  2004-05       Impact factor: 29.983

4.  Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome.

Authors:  Hiroshi Morita; Kengo Kusano-Fukushima; Satoshi Nagase; Yoshihisa Fujimoto; Kenichi Hisamatsu; Hideki Fujio; Kayo Haraoka; Makoto Kobayashi; Shiho Takenaka Morita; Kazufumi Nakamura; Tetsuro Emori; Hiromi Matsubara; Kazumasa Hina; Toshimasa Kita; Masahiko Fukatani; Tohru Ohe
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

  4 in total
  1 in total

Review 1.  The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Authors:  Johannes Steinfurt; Jürgen Biermann; Christoph Bode; Katja E Odening
Journal:  Dtsch Arztebl Int       Date:  2015-06-05       Impact factor: 5.594

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.